Trial suggests RRx-001 effective for oral mucositis following head and neck chemoradiotherapy
Hospital Pharmacy Europe
JANUARY 28, 2023
Moreover, data suggests that the compound is able to selectively protect normal cells, while inducing apoptosis within tumour cells. Overall, there were no severe adverse reactions attributed to the drug. The severity of OM was assessed using the WHO grading scale and the incidence of severe OM was bases on WHO scores > 3.
Let's personalize your content